Amiselimod
- Generic Name
- Amiselimod
- Drug Type
- Small Molecule
- Chemical Formula
- C19H30F3NO3
- CAS Number
- 942399-20-4
- Unique Ingredient Identifier
- 358M5150LY
Extension Study of MT-1303 in Subjects With Crohn's Disease
- First Posted Date
- 2015-03-17
- Last Posted Date
- 2017-09-05
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Target Recruit Count
- 46
- Registration Number
- NCT02389790
- Locations
- 🇺🇦
Investigational site, City Name, Ukraine
Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease
- First Posted Date
- 2015-03-04
- Last Posted Date
- 2016-10-14
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Target Recruit Count
- 78
- Registration Number
- NCT02378688
- Locations
- 🇺🇦
Investigational site, City Name, Ukraine
🇩🇪Investigational Site, City Name, Germany
Mass Balance Study of MT-1303
- First Posted Date
- 2014-11-19
- Last Posted Date
- 2015-03-17
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Target Recruit Count
- 8
- Registration Number
- NCT02293967
- Locations
- 🇬🇧
Investigational site, Ruddington, Nottingham, United Kingdom
Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Study of MT-1303 in Subjects With Crohn's Disease
- First Posted Date
- 2014-05-28
- Last Posted Date
- 2014-09-12
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Target Recruit Count
- 1
- Registration Number
- NCT02148185
- Locations
- 🇯🇵
Inverstigational site, Kanto, Japan
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of MT-1303 in Subjects With Inflammatory Bowel Disease
- First Posted Date
- 2012-08-16
- Last Posted Date
- 2014-09-05
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Target Recruit Count
- 18
- Registration Number
- NCT01666327
- Locations
- 🇬🇧
Research Site, Nottingham, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath